Skip to content

Krystal Biotech, Inc. KRYS Accrued payroll and benefits

Other financials

Income statement

See full
Revenue$116.4M+31.9%
Operating income$53.7M+48.1%
Net income$55.9M+56.5%
EPS (diluted)$1.83+52.5%

Balance sheet

See full
Cash & equivalents$501.3M+62.4%
Total debt$9.1M-5.7%
Total equity$1.3B+29.7%
Total assets$1.4B+30.0%

Cash flow

See full
Operating cash flow$80.4M+160%
CapEx$7.1M+15.2%
Free cash flow$73.2M+196%

Valuation

See full
Market cap$10.26B+45.4%
Enterprise value$9.77B+44.2%
P/E45.6×-11.3×
P/S24.6×+3.4×

Profitability

See full
Operating margin42.8%+10.2pp
Net margin53.9%+16.7pp
FCF margin56.9%+16.5pp

Returns & leverage

See full
Return on equity19.9%+6.0pp
Debt / equity0.0×
Current ratio9.5×-0.2×

Where this comes from

Reported directly by Krystal Biotech, Inc. in its filing.

Tagged under the XBRL concept krys:AccruedPayrollAndBenefits.

The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Krystal Biotech, Inc.'s accrued payroll and benefits.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Krystal Biotech, Inc.'s accrued payroll and benefits?
Krystal Biotech, Inc. (KRYS) reported accrued payroll and benefits of $4.94M in Q1 2026.
How has Krystal Biotech, Inc.'s accrued payroll and benefits changed year-over-year?
Krystal Biotech, Inc.'s accrued payroll and benefits increased by 41.6% year-over-year, from $3.49M to $4.94M.
What is the long-term trend for Krystal Biotech, Inc.'s accrued payroll and benefits?
Over 5 years (2020 to 2025), Krystal Biotech, Inc.'s accrued payroll and benefits has grown at a 50.5% compound annual growth rate (CAGR), from $1.49M to $11.46M.